Login / Signup

A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA).

Brandon D AyresMarc R BloomensteinJennifer LohThomas ChesterBobby SaenzJulio EchegoyenShane R KannarrVictor L PerezTomasita C RodriguezJaime E Dickerson
Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)
TC provides statistically superior and sustained improvement in TBUT and multiple measures of meibomian gland secretion, and non-inferior improvement in OSDI, corneal and conjunctival staining, SANDE, EDS, and STS versus CsA. TC should be a preferred treatment for DED associated with MGD.
Keyphrases
  • combination therapy
  • wound healing